# Smartbeam

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/smartbeam

- Industry: Medical Devices & Equipment
- Headquarters: Beijing, China
- Website: www.bjsmartbeam.com
- Latest round: Series A (Feb 8, 2023)
- Investors on record: 6

## About

Established in 2019 and based in Beijing, China, Beijing Zhishu Technology Co., Ltd., dba Smartbeam, operates as  a medical device company that focuses on the independent development, production and sales of core vacuum electronic devices such as CT bulbs. It completed the qualified product of ball bearing CT ball tube and experimental sample of liquid metal bearing CT ball tube in January 2020 and obtained the medical device registration and manufacturing license for CT ball tube and ISO9001 and ISO13485 management system certification in December 2021. In December 2025, Smartbeam closed a venture funding from new investor raised an undisclosed amount of venture funding from new investor.

The company's main business is the research, development, production and sales of core vacuum electronic devices such as CT bulbs. It self-developed products such as ZS502L X-ray tube assembly, ZS302B X-ray tube assembly, and ZS402L X-ray tube assembly. Its products are used in medical imaging, tumor treatment, safety testing, electronic irradiation, and other medical devices.

The company generates revenue by providing producingand selling vacuum electronic devices such as CT tubes.

## Funding rounds

- Series A, Feb 8, 2023 — Beijing Haina Yourong Capital, Wonderland Capital, Shenzhen Jiagengxin Investment
- Series A, Jul 23, 2021 — Beijing Peakvalley Capital Investment
- Angel, Apr 2, 2020 — Hengying Fund, HiMed Angle Fund Management

## Investors

- Hengying Fund — Angel
- HiMed Angle Fund Management (https://capitalatlas.ai/funds/himed-angle-fund-management) — Angel
- Beijing Peakvalley Capital Investment — Series A
- Beijing Haina Yourong Capital (https://capitalatlas.ai/funds/beijing-haina-yourong-capital) — Series A
- Wonderland Capital — Series A
- Shenzhen Jiagengxin Investment — Series A